Overcoming AI’s Biggest Blocker in Drug Discovery:
How Knowledge Graphs Turn Disparate Data, Literature, and Evidence into a Reasoning-Ready System

LIVE WEBINAR
Thursday, November 5th | 11am ET

Duration: 1 hour
Can't make the live date? Register and we'll send you a link to the recording. ​


AI is transforming drug discovery, but its impact is limited without a coherent knowledge layer for biological reasoning. There's no unifying glue that connects the disparate pieces of data, literature, and evidence into AI-suitable inputs. Or is there? Researchers are starting to think knowledge graphs can be that glue.

Drawing on the expertise of Jesper Ryge, PhD (Director & Head, Computational Biology in Neuroscience & Immunology, Merck KGaA), and Humberto Bastos (Vice President of Sales, Americas, QIAGEN), this session will unpack how knowledge graphs unify multiomics data, literature, and experimental evidence into a reasoning-ready system.

You'll learn:

  • How graph-based discovery and disease mechanism mapping constrain AI to relevant evidence subgraphs
  • How you can ensure AI-generated answers are defensible and traceable to specific citations
  • Why expert human curation is essential for building evidence-based systems
 

SPEAKERS

Jesper Ryge, PhD
Jesper Ryge, PhD
Director, Computational Biology
Merck KgaA
 


Humberto Bastos
Humberto Bastos
Vice President of Sales, Americas
QIAGEN Digital Insight 
 

REGISTER NOW

Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor

Industry Dive is an Informa TechTarget business.
© 2026 TechTarget, Inc. or its subsidiaries. All rights reserved. | Privacy Policy | Terms of Use​